Individual tickets are $500 each. You can purchase tickets online or complete and return the Individual Ticket section of the Sponsor Form.

Learn More


Learn about sponsorship opportunities for you and your company to recognize our Honoree and support Care+Cure in the fight to END EPILEPSY for children. Purchase a sponsorship online or complete and return the Sponsorship Form.

Learn More

Event Chairs

Mark Borman

Andrew Gumpert

Honorary Committee

Patrick Whitesell

Patrick Wachsberger

Michael De Luca

Lorenzo di Bonaventura

Bryan Lourd

Amy Pascal

Todd Black

Jason Blumenthal

Steve Tisch

Brad Weston

Our 2016 Honoree Doug Belgrad

President, Sony Pictures Entertainment Motion Picture Group

Doug Belgrad is President of SPE’s Motion Picture Group and the President of Columbia Pictures. In his Motion Picture Group role, Belgrad integrates creative decision-making, business and financial planning across all of SPE’s film labels and manages the creative staff at the studio. He is also responsible for the development and production of all films produced by Columbia Pictures.

Belgrad joined SPE in 1989 and rose to co-president of Production at Columbia Pictures in 2003, becoming president of the label five years later. He has bought, developed and supervised a long list of commercially successful and critically acclaimed films, including the Men In Black franchise, Bad Boys I & II, the Jump Street movies, The Social Network, Hitch, Hancock, a dozen Adam Sandler films, including the Grown-Ups pictures, The Karate Kid, American Hustle, Captain Phillips, Zero Dark Thirty, Bad Teacher, and The Equalizer. Belgrad is currently overseeing the re-launch of the Ghostbusters brand and upcoming films, including Passengers, starring Jennifer Lawrence and Chris Pratt, Inferno, starring Tom Hanks, and Magnificent 7, starring Denzel Washington and Chris Pratt.

Belgrad graduated from the University of Pennsylvania in 1987 with a B.A. in history. He began his career at Kidder, Peabody as a securities analyst, specializing in media and entertainment companies. As a dedicated and generous supporter of the Epilepsy Foundation of Greater Los Angeles, we are thrilled to have him serve as our 2016 CARE AND CURE honoree.

1 in 26 people will be diagnosed with Epilepsy in his or her lifetime.

Other Facts

  • 1 in 26 will be diagnosed with epilepsy in their lifetime
  • The epilepsies affect almost 3 million people in the USA, and 160,000 of them live in our region.
  • There are more people with epilepsy than the number of people with cerebal palsy, muscular dystrophy, multiple sclerosis and Parkinson’s disease — combined.
  • About 50,000 people die each year from seizures and seizure related causes. That’s more than the number of deaths due to breast cancer.
  • Uncontrolled seizures can damage the developing brain and early diagnosis and treatment are critical.
  • Federal research funding is sorely inadequate. To give you a comparison, what the NIH allocated to research amounts to about $59 per person with epilepsy compared to $280 per person with MS.

Our Goal

Our ultimate goal is no child diagnosed with epilepsy. Until then your support ensures that children with epilepsy can get specialty care and that epilepsy research thrives in our region — giving children and their families ever greater hope for cures.


While there is still much to be done, we are very proud of our accomplishments. The previous CARE AND CURE Benefits have supported and/or are currently supporting:

  • 20 Fellow/Faculty at UCLA, LAC + USC, CHLA and UCSF
  • 7 Research projects (including stem cell)
  • 3 Pediatric Dietary Therapy Programs - UCLA, LAC + USC and CHLA
  • 16 events that connect families of children with epilepsy
  • 4 years of statewide advocacy for children with epilepsy
  • 2,400 students were educated about how to perform seizure first aid


We fulfill our mission by leading the fight to END EPILEPSY®. We dedicate the CARE AND CURE Benefit to thousands of children with epilepsy who urgently need specialty care while we accelerate research for cures.